A distinct innate immune signature marks progression from mild to severe COVID-19

Coronavirus disease 2019 (COVID-19) manifests with a range of severities, but immune signatures of mild and severe disease are still not fully understood. Here, we use mass cytometry and targeted proteomics to profile the innate immune response of patients with mild or severe COVID-19 and of healthy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep Med
Main Authors: Chevrier, Stéphane, Zurbuchen, Yves, Cervia, Carlo, Adamo, Sarah, Raeber, Miro E., de Souza, Natalie, Sivapatham, Sujana, Jacobs, Andrea, Bachli, Esther, Rudiger, Alain, Stüssi-Helbling, Melina, Huber, Lars C., Schaer, Dominik J., Nilsson, Jakob, Boyman, Onur, Bodenmiller, Bernd
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7817872/
https://ncbi.nlm.nih.gov/pubmed/33521697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados